Quinupristin
CAS No. 120138-50-3
Quinupristin ( —— )
Catalog No. M26404 CAS No. 120138-50-3
Quinupristin is a streptogramin antibiotic. Quinupristin blocks peptide bond synthesis to prevent the extension of polypeptide chains and promote the detachment of incomplete protein chains in the bacterial ribosomal subunits [2].
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 159 | Get Quote |
|
5MG | 281 | Get Quote |
|
10MG | 431 | Get Quote |
|
25MG | 761 | Get Quote |
|
50MG | 1078 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameQuinupristin
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuinupristin is a streptogramin antibiotic. Quinupristin blocks peptide bond synthesis to prevent the extension of polypeptide chains and promote the detachment of incomplete protein chains in the bacterial ribosomal subunits [2].
-
DescriptionQuinupristin is a streptogramin antibiotic. Quinupristin blocks peptide bond synthesis to prevent the extension of polypeptide chains and promote the detachment of incomplete protein chains in the bacterial ribosomal subunits [2].(In Vitro):Quinupristin/dalfopristin is a combination of streptogramin antibiotics used to against infections. Quinupristin/dalfopristin is reportedly effective against Mycoplasma spp.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorCereblon
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number120138-50-3
-
Formula Weight1022.2
-
Molecular FormulaC53H67N9O10S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)c1ncccc1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN1C(=O)[C@]([H])(Cc1ccc(cc1)N(C)C)N(C)C2=O)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
-
Pactamycin
Pactamycin (NSC 52947) is a potent protein synthesis inhibitor.
-
Imipenem
Imipenem (MK-0787) is a broad-spectrum, semi-synthetic beta-lactam carbapenem that has broad antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria.
-
Proanthocyanidins(b)
Proanthocyanidins is a natural produceused as antioxidant and anti-cancers agent.?